PSA launches new guide to naloxone supply


sad man in front of graffitied wall: harm minimisation story

A new guide to inform pharmacists about the safe and effective supply of naloxone has been released by the PSA.

The comprehensive guide has been produced following the TGA’s decision to broaden the scheduling of naloxone – a life-saving medicine used to for opioid overdose – to include a Schedule 3 listing.

This means from 1 February 2016, a prescription is no longer required for naloxone, which is now available over-the-counter through pharmacies across Australia.

PSA National President Joe Demarte says the naloxone guide will help to ensure pharmacists are aware of and can fulfil their professional responsibilities.

“The PSA naloxone guide will be a very useful tool for Australian pharmacists, who must also meet State-based legislative requirements,” Demarte says.

“Pharmacists are expected to exercise professional judgement in adapting the guidance to presenting circumstances.”

Demarte says the single-use, pre-filled naloxone syringe is a medicine that will help to save lives across Australia.

“Previously patients were required to go to their doctor to get a prescription then visit their pharmacy to receive naloxone – this scheduling change means people can now access the medicine directly from a pharmacy,” Demarte says.

“Having this life-saving medicine available through Australian pharmacies is also an important step in harm minimisation.”

The PSA has also recorded a webinar by community pharmacist Angelo Pricolo, a CPD activity on the provision of naloxone as a Pharmacist-Only medicine and provided PSA members with links to additional supporting resources.

Previous Opioid use quadruples in Australia, but others can't access pain relief
Next Dental health resources for cancer patients

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.